Tate & Lyle Acquires Winway Biotechnology, a Leading Chinese Polydextrose Business

London, UK, 13 March 2014 – Tate & Lyle PLC (“Tate & Lyle”), a leading global provider of speciality food ingredients and solutions, announces that it has signed an agreement to acquire the business and assets of Winway Biotechnology Nantong Co. Ltd (“Winway”), a leading producer of polydextrose speciality fibre in the People’s Republic of China.

The transaction is subject to governmental approval which is expected later in the year.

Winway operates from a manufacturing facility and laboratories in Nantong, Jiangsu Province, where it produces a range of polydextrose products which are sold to customers in China and worldwide. Tate & Lyle intends to invest in the Nantong facility over the next two years to expand capacity and enhance its speciality fibre product offering. Nantong will become Tate & Lyle’s third polydextrose facility globally, in addition to existing lines in the Netherlands and the US.

Polydextrose is a premium, low calorie bulking agent and dietary fibre. It plays a key role in replacing the technical functionality of sugar, providing bulk, body, texture and mouthfeel in reduced calorie, no-added-sugar and/or high fibre foods. A soluble dietary fibre with prebiotic properties, polydextrose helps support gastrointestinal health, is very well tolerated, has a low glycemic/blood glucose response, and is clean tasting and easy to use.

Polydextrose is one of Tate & Lyle’s growing range of speciality fibres which includes PROMITOR^® Soluble Corn Fibre, PROMITOR^® Soluble Gluco Fibre and PromOat^® Beta Glucan.

Olivier Rigaud, President, Speciality Food Ingredients for Tate & Lyle said: “The acquisition of Winway provides us with an excellent platform from which to accelerate the growth of our specialty fibres business in Asia Pacific, and to expand our Health and Wellness offering globally.”

End

For more information contact Tate & Lyle PLC:

Mathew Wootton
Group VP, Investor & Media Relations
t:+44 (0)20 7257 2110
m:+44 (0)7500 100 320
e: [email protected]

泰莱收购中国领先的聚葡萄糖企业博程生物科技

英国伦敦，2014年3月[13]日 – 全球领先的特种食品配料和解决方案供应商Tate & Lyle PLC (“泰莱”)宣布其已经签署了一份协议，收购中国领先的聚葡萄糖特种纤维生产商博程生物科技南通有限公司(“博程”)的业务和资产。

此项交易还有待政府批准，预计将在今年晚些时候获得政府批准。

博程的生产场所和实验室位于江苏省南通市，生产一系列聚葡萄糖产品，供应中国和全球的客户。泰莱打算在接下来的两年内对南通工厂进行投资，扩大产能并增加特种纤维产品供应。除在荷兰和美国的现有生产线外，南通工厂将成为泰莱在全球的第三个聚葡萄糖生产厂。

聚葡萄糖是一种优质的低热量填充剂和膳食纤维，具有替代糖的功能特质， 可以在低热量、不添加糖和/或高纤维食物中提供纤维性物质，提升稠度、质地和口感。聚葡萄糖是一种具有益生元特性的可溶性膳食纤维，有助于支持肠胃健康，有非常好的耐受性，升糖/血糖反应小，味道清醇而易于使用。

聚葡萄糖是泰莱范围越来越广的特种膳食纤维之一，包括PROMITOR®可溶性玉米纤维，PROMITOR®可溶性葡萄糖纤维和PromOat®贝塔葡聚糖。

泰莱特种食品配料部总裁Olivier Rigaud先生指出：“此次收购博程，为我们提供了一个优秀的平台，我们可以从这个平台加快我们的特种膳食纤维业务在亚太地区的发展并在全球扩大我们的健康与保健产品供应。”

最后部分

如需了解更多信息，请联系Tate & Lyle PLC：

Mathew Wootton
Group VP, Investor & Media Relations
电话：+44 (0)20 7257 2110
手机：+44 (0)7500 100 320
电邮：[email protected]

关于泰莱(Tate & Lyle)：

泰莱是一家为食品、饮料和其它工业客户提供配料和解决方案的全球供应商，其在世界各地拥有30多家工厂。

泰莱通过两个全球业务部开展业务：特种食品配料部和大宗配料部，并由公司的创新和商业发展部进行支持。集团公司的战略是通过有计划的增长方式成为全球领先的特种食品配料的供应商，并通过大宗配料的业务来持续提供现金以加速这一增长。

特种食品配料包括淀粉类特种配料(玉米类特种淀粉、甜味剂和纤维)，无热量甜味剂(包括善品®糖™蔗糖素)和食品系统，提供复配解决方案。大宗配料包括玉米类大宗甜味剂、工业用淀粉和发酵产品(主要是酸度剂)。来自两个业务部的副产品主要作为动物饲料销售。

泰莱在伦敦证券交易所上市，交易代码为TATE.L。美国存托凭证交易名为TATYY。截至2013年3月31日，泰莱的总销售额为33亿英镑。https://www.tateandlyle.com. SPLENDA^®是McNeil Nutritionals, LLC的商标。